New drug interaction study completed: no cure, just crucial safety data
NCT ID NCT06948747
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times
Summary
This study looked at how a new experimental drug, AZD5004, affects the way the body processes several common medicines, including statins (for cholesterol) and repaglinide (for diabetes). It also checked how another drug, erythromycin (an antibiotic), affects AZD5004. The study involved 49 healthy adults aged 18 to 55. The goal was purely to gather safety and dosing information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Brooklyn, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.